+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Structural Heart Occlusion Devices Market Size, Share & Trends Analysis Report by Type (Left Atrial Appendage (LAA) Occlusion Devices, Atrial Septal Defect (ASD) Occluders), End-use (Hospitals, Specialty Clinics), and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 140 Pages
  • May 2025
  • Region: Global
  • Grand View Research
  • ID: 6098215
Description Jump to:
The Structural Heart Occlusion Devices Market was valued at USD 4.0 billion in 2024, and is projected to reach USD 6.0 billion by 2030, rising at a CAGR of 7.00%. The structural heart occlusion devices market is advancing due to the rising burden of structural heart diseases, increasing acceptance of minimally invasive therapies, and favorable regulatory and reimbursement changes. Growing clinical awareness and procedural innovations are expanding the eligible patient pool, reinforcing a strong positive growth outlook.

The increasing prevalence of structural heart diseases is a major driver for the structural heart occlusion devices market. Conditions such as atrial septal defects, patent foramen ovale, and left atrial appendage abnormalities are gaining greater clinical attention as diagnostic technologies continue to advance. The American Heart Association's 2024 Statistical Update projects that the prevalence of atrial fibrillation (AF) in the U.S. will rise from approximately 5.2 million in 2010 to 12.1 million by 2030, underscoring the growing clinical need for effective interventions. As awareness improves and diagnostic pathways become more standardized, the addressable patient population for occlusion therapies is expanding significantly, creating a strong foundation for market growth.

As the prevalence of atrial fibrillation (AF) continues to rise globally, Left Atrial Appendage Occlusion (LAAO) procedures are gaining traction within the Structural Heart Occlusion Devices market. LAAO offers a non-pharmacologic alternative to oral anticoagulants for stroke prevention in patients with non-valvular AF, particularly those at high bleeding risk. A February 2025 article published in the European Heart Journal Supplements focused on the growing adoption of LAAO for patients with contraindications to long-term oral anticoagulant therapy (OAT). The article emphasizes that despite OAT's role in stroke prevention, certain patients, especially those with a history of bleeding events, remain at high risk for ischemic strokes.

Regulatory and reimbursement initiatives are playing an increasingly important role in shaping the structural heart occlusion devices market. Favorable policy environments are essential to encourage clinical adoption, promote investment in innovation, and expand patient access to advanced therapies. In March 2025, the Centers for Medicare & Medicaid Services (CMS) approved the REDUCE-AF clinical trial under Coverage with Evidence Development (CED) to evaluate the LAmbre Plus Left Atrial Appendage Closure System. This decision reflects continued regulatory emphasis on building robust clinical evidence to support device utilization in patients with non-valvular atrial fibrillation.

Global Structural Heart Occlusion Devices Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2018 to 2030. For this study, the analyst has segmented the global structural heart occlusion devices market report based on type, end-use, and region:

Type Outlook (Revenue, USD Million, 2018-2030)

  • Left Atrial Appendage (LAA) Occlusion Devices
  • Atrial Septal Defect (ASD) Occluders
  • Patent Ductus Arteriosus (PDA) Occlusion Devices
  • Others

End-use Outlook (Revenue, USD Million, 2018-2030)

  • Hospitals
  • Specialty clinics
  • Academic and Research Institutes

Regional Outlook (Revenue, USD Million, 2018-2030)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia-Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. End Use
1.2.3. Regional scope
1.2.4. Estimates and forecast timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity price analysis (Model 1)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type Segment
2.2.2. End Use Segment
2.2.3. Regional Outlook
2.3. Competitive Insights
Chapter 3. Global Structural Heart Occlusion Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising prevalence of structural heart diseases
3.2.1.2. Growth of minimally invasive cardiac interventions
3.2.1.3. Regulatory and reimbursement tailwinds
3.2.2. Market restraint analysis
3.2.2.1. Regulatory approval delays
3.3. Structural Heart Occlusion Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Structural Heart Occlusion Devices Market: Type Estimates & Trend Analysis
4.1. Structural Heart Occlusion Devices Market: Type Dashboard
4.2. Structural Heart Occlusion Devices Market: Type Movement Analysis
4.3. Structural Heart Occlusion Devices Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Left Atrial Appendage (LAA) Occlusion Devices
4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5. Atrial Septal Defect (ASD) Occluders
4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.6. Patent Ductus Arteriosus (PDA) Occlusion Devices
4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.7. Others
4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Structural Heart Occlusion Devices Market: End Use Estimates & Trend Analysis
5.1. Structural Heart Occlusion Devices Market: End Use Dashboard
5.2. Structural Heart Occlusion Devices Market: End Use Movement Analysis
5.3. Structural Heart Occlusion Devices Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
5.4. Hospitals
5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5. Specialty Clinics
5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.6. Academic and Research Institutes
5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Structural Heart Occlusion Devices Market: Regional Estimates & Trend Analysis by Country, Type, Indication, & End Use
6.1. Global Structural Heart Occlusion Devices Market: Regional Dashboard
6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
6.3. North America
6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.3.2. U.S.
6.3.2.1. Key country dynamics
6.3.2.2. Regulatory framework/ reimbursement structure
6.3.2.3. Competitive scenario
6.3.2.4. U.S. market estimates and forecast, 2018-2030 (USD Million)
6.3.3. Canada
6.3.3.1. Key country dynamics
6.3.3.2. Regulatory framework/ reimbursement structure
6.3.3.3. Competitive scenario
6.3.3.4. Canada market estimates and forecast, 2018-2030 (USD Million)
6.3.4. Mexico
6.3.4.1. Key country dynamics
6.3.4.2. Regulatory framework/ reimbursement structure
6.3.4.3. Competitive scenario
6.3.4.4. Mexico market estimates and forecast, 2018-2030 (USD Million)
6.4. Europe
6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.2. UK
6.4.2.1. Key country dynamics
6.4.2.2. Regulatory framework/ reimbursement structure
6.4.2.3. Competitive scenario
6.4.2.4. UK market estimates and forecast, 2018-2030 (USD Million)
6.4.3. Germany
6.4.3.1. Key country dynamics
6.4.3.2. Regulatory framework/ reimbursement structure
6.4.3.3. Competitive scenario
6.4.3.4. Germany market estimates and forecast, 2018-2030 (USD Million)
6.4.4. France
6.4.4.1. Key country dynamics
6.4.4.2. Regulatory framework/ reimbursement structure
6.4.4.3. Competitive scenario
6.4.4.4. France market estimates and forecast, 2018-2030 (USD Million)
6.4.5. Italy
6.4.5.1. Key country dynamics
6.4.5.2. Regulatory framework/ reimbursement structure
6.4.5.3. Competitive scenario
6.4.5.4. Italy market estimates and forecast, 2018-2030 (USD Million)
6.4.6. Spain
6.4.6.1. Key country dynamics
6.4.6.2. Regulatory framework/ reimbursement structure
6.4.6.3. Competitive scenario
6.4.6.4. Spain market estimates and forecast, 2018-2030 (USD Million)
6.4.7. Sweden
6.4.7.1. Key country dynamics
6.4.7.2. Regulatory framework/ reimbursement structure
6.4.7.3. Competitive scenario
6.4.7.4. Sweden market estimates and forecast, 2018-2030 (USD Million)
6.4.8. Norway
6.4.8.1. Key country dynamics
6.4.8.2. Regulatory framework/ reimbursement structure
6.4.8.3. Competitive scenario
6.4.8.4. Norway market estimates and forecast, 2018-2030 (USD Million)
6.4.9. Denmark
6.4.9.1. Key country dynamics
6.4.9.2. Regulatory framework/ reimbursement structure
6.4.9.3. Competitive scenario
6.4.9.4. Denmark market estimates and forecast, 2018-2030 (USD Million)
6.5. Asia Pacific
6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.2. China
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. China market estimates and forecast, 2018-2030 (USD Million)
6.5.3. Japan
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. Japan market estimates and forecast, 2018-2030 (USD Million)
6.5.4. India
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/ reimbursement structure
6.5.4.3. Competitive scenario
6.5.4.4. India market estimates and forecast, 2018-2030 (USD Million)
6.5.5. Australia
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework/ reimbursement structure
6.5.5.3. Competitive scenario
6.5.5.4. Australia market estimates and forecast, 2018-2030 (USD Million)
6.5.6. Thailand
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework/ reimbursement structure
6.5.6.3. Competitive scenario
6.5.6.4. Thailand market estimates and forecast, 2018-2030 (USD Million)
6.5.7. South Korea
6.5.7.1. Key country dynamics
6.5.7.2. Regulatory framework/ reimbursement structure
6.5.7.3. Competitive scenario
6.5.7.4. South Korea market estimates and forecast, 2018-2030 (USD Million)
6.6. Latin America
6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.2. Brazil
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Brazil market estimates and forecast, 2018-2030 (USD Million)
6.6.3. Argentina
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. Argentina market estimates and forecast, 2018-2030 (USD Million)
6.7. MEA
6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.7.2. Saudi Arabia
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. Saudi Arabia market estimates and forecast, 2018-2030 (USD Million)
6.7.3. South Africa
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/ reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. South Africa market estimates and forecast, 2018-2030 (USD Million)
6.7.4. UAE
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/ reimbursement structure
6.7.4.3. Competitive scenario
6.7.4.4. UAE market estimates and forecast, 2018-2030 (USD Million)
6.7.5. Kuwait
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework/ reimbursement structure
6.7.5.3. Competitive scenario
6.7.5.4. Kuwait market estimates and forecast, 2018-2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Manufacturers
7.2. Company/Competition Categorization
7.3. Key company market share analysis, 2024
7.3.1. Abbott
7.3.1.1. Company overview
7.3.1.2. Financial performance
7.3.1.3. Product benchmarking
7.3.1.4. Strategic initiatives
7.3.2. Boston Scientific Corporation
7.3.2.1. Company overview
7.3.2.2. Financial performance
7.3.2.3. Product benchmarking
7.3.2.4. Strategic initiatives
7.3.3. Occlutech
7.3.3.1. Company overview
7.3.3.2. Financial performance
7.3.3.3. Product benchmarking
7.3.3.4. Strategic initiatives
7.3.4. Lifetech Scientific
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Medtronic
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. W. L. Gore & Associates
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Lepu Medical Technology (Beijing)Co.,Ltd
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Emtree Medical (Cardia Inc.)
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Biosense Webster (Johnson & Johnson)
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. PFM Medical GMBH
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 Global structural heart occlusion devices market, by type 2018-2030 (USD Million)
Table 4 Global structural heart occlusion devices market, by end use, 2018-2030
Table 5 Global structural heart occlusion devices market, by region, 2018-2030 (USD Million)
Table 6 North America structural heart occlusion devices market, by country, 2018-2030 (USD Million)
Table 7 North America structural heart occlusion devices market, by type, 2018-2030 (USD Million)
Table 8 North America structural heart occlusion devices market, by end use, 2018-2030 (USD Million)
Table 9 U.S structural heart occlusion devices market, by type, 2018-2030 (USD Million)
Table 10 U.S structural heart occlusion devices market, by end use, 2018-2030 (USD Million)
Table 11 Canada structural heart occlusion devices market, by type, 2018-2030 (USD Million)
Table 12 Canada structural heart occlusion devices market, by end use, 2018-2030 (USD Million)
Table 13 Mexico structural heart occlusion devices market, by type, 2018-2030 (USD Million)
Table 14 Mexico structural heart occlusion devices market, by end use, 2018-2030 (USD Million)
Table 15 Europe structural heart occlusion devices market, by country, 2018-2030 (USD Million)
Table 16 Europe structural heart occlusion devices market, by type, 2018-2030 (USD Million)
Table 17 Europe structural heart occlusion devices market, by end use, 2018-2030 (USD Million)
Table 18 UK structural heart occlusion devices market, by type, 2018-2030 (USD Million)
Table 19 UK structural heart occlusion devices market, by end use, 2018-2030 (USD Million)
Table 20 Germany structural heart occlusion devices market, by type, 2018-2030 (USD Million)
Table 21 Germany structural heart occlusion devices market, by end use, 2018-2030 (USD Million)
Table 22 France structural heart occlusion devices market, by type, 2018-2030 (USD Million)
Table 23 France structural heart occlusion devices market, by end use, 2018-2030 (USD Million)
Table 24 Italy structural heart occlusion devices market, by type, 2018-2030 (USD Million)
Table 25 Italy structural heart occlusion devices market, by end use, 2018-2030 (USD Million)
Table 26 Spain structural heart occlusion devices market, by type, 2018-2030 (USD Million)
Table 27 Spain structural heart occlusion devices market, by end use, 2018-2030 (USD Million)
Table 28 Denmark structural heart occlusion devices market, by type, 2018-2030 (USD Million)
Table 29 Denmark structural heart occlusion devices market, by end use, 2018-2030 (USD Million)
Table 30 Sweden structural heart occlusion devices market, by type, 2018-2030 (USD Million)
Table 31 Sweden structural heart occlusion devices market, by end use, 2018-2030 (USD Million)
Table 32 Norway structural heart occlusion devices market, by type, 2018-2030 (USD Million)
Table 33 Norway structural heart occlusion devices market, by end use, 2018-2030 (USD Million)
Table 34 Asia Pacific structural heart occlusion devices market, by country, 2018-2030 (USD Million)
Table 35 Asia Pacific structural heart occlusion devices market, by type, 2018-2030 (USD Million)
Table 36 Asia Pacific structural heart occlusion devices market, by end use, 2018-2030 (USD Million)
Table 37 Japan structural heart occlusion devices market, by type, 2018-2030 (USD Million)
Table 38 Japan structural heart occlusion devices market, by end use, 2018-2030 (USD Million)
Table 39 China structural heart occlusion devices market, by type, 2018-2030 (USD Million)
Table 40 China structural heart occlusion devices market, by end use, 2018-2030 (USD Million)
Table 41 India structural heart occlusion devices market, by type, 2018-2030 (USD Million)
Table 42 India structural heart occlusion devices market, by end use, 2018-2030 (USD Million)
Table 43 Australia structural heart occlusion devices market, by country, 2018-2030 (USD Million)
Table 44 Australia structural heart occlusion devices market, by type, 2018-2030 (USD Million)
Table 45 Australia structural heart occlusion devices market, by end use, 2018-2030 (USD Million)
Table 46 Thailand structural heart occlusion devices market, by type, 2018-2030 (USD Million)
Table 47 Thailand structural heart occlusion devices market, by end use, 2018-2030 (USD Million)
Table 48 South Korea structural heart occlusion devices market, by type, 2018-2030 (USD Million)
Table 49 South Korea structural heart occlusion devices market, by end use, 2018-2030 (USD Million)
Table 50 Latin America structural heart occlusion devices market, by country, 2018-2030 (USD Million)
Table 51 Latin America structural heart occlusion devices market, by type, 2018-2030 (USD Million)
Table 52 Latin America structural heart occlusion devices market, by end use, 2018-2030 (USD Million)
Table 53 Brazil structural heart occlusion devices market, by type, 2018-2030 (USD Million)
Table 54 Brazil structural heart occlusion devices market, by end use, 2018-2030 (USD Million)
Table 55 Argentina structural heart occlusion devices market, by type, 2018-2030 (USD Million)
Table 56 Argentina structural heart occlusion devices market, by end use, 2018-2030 (USD Million)
Table 57 MEA structural heart occlusion devices market, by country, 2018-2030 (USD Million)
Table 58 MEA structural heart occlusion devices market, by type, 2018-2030 (USD Million)
Table 59 MEA structural heart occlusion devices market, by end use, 2018-2030 (USD Million)
Table 60 South Africa structural heart occlusion devices market, by type, 2018-2030 (USD Million)
Table 61 South Africa structural heart occlusion devices market, by end use, 2018-2030 (USD Million)
Table 62 Saudi Arabia structural heart occlusion devices market, by type, 2018-2030 (USD Million)
Table 63 Saudi Arabia structural heart occlusion devices market, by end use, 2018-2030 (USD Million)
Table 64 UAE structural heart occlusion devices market, by type, 2018-2030 (USD Million)
Table 65 UAE structural heart occlusion devices market, by end use, 2018-2030 (USD Million)
Table 66 Kuwait structural heart occlusion devices market, by type, 2018-2030 (USD Million)
Table 67 Kuwait structural heart occlusion devices market, by end use, 2018-2030 (USD Million)
Table 68 Participant’s overview
Table 69 Financial performance
Table 70 Key companies undergoing expansions
Table 71 Key companies undergoing acquisitions
Table 72 Key companies undergoing collaborations
Table 73 Key companies launching new products
Table 74 Key companies undergoing partnerships
Table 75 Key companies undertaking other strategies
List of Figures
Figure 1 Structural heart occlusion devices market segmentation
Figure 2 Market research process
Figure 3 Information procurement
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value chain-based sizing & forecasting
Figure 7 QFD modelling for market share assessment
Figure 8 Structural heart occlusion devices market revenues, 2024 (USD Millions)
Figure 9 Market driver relevance analysis (Current & future impact)
Figure 10 Market restraint relevance analysis (Current & future impact)
Figure 11 Porter’s five forces analysis
Figure 12 PESTLE analysis
Figure 13 Structural heart occlusion devices market Type outlook
Figure 14 Structural heart occlusion devices market: Type movement analysis
Figure 15 Segment dashboard
Figure 16 Global left atrial appendage (LAA) occlusion devices market, 2018-2030 (USD Million)
Figure 17 Global atrial septal defect (ASD) occluders market, 2018-2030 (USD Million)
Figure 18 Global patent ductus arteriosus (PDA) occlusion devices market, 2018-2030 (USD Million)
Figure 19 Global others market, 2018-2030 (USD Million)
Figure 20 Structural heart occlusion devices market end use outlook
Figure 21 Structural heart occlusion devices market: end use movement analysis
Figure 22 Global hospitals market, 2018-2030 (USD Million)
Figure 23 Global specialty clinics market, 2018-2030 (USD Million)
Figure 24 Global academic and research institutes market, 2018-2030 (USD Million)
Figure 25 Regional market place: Key takeaways
Figure 26 North America structural heart occlusion devices market, 2018-2030 (USD Million)
Figure 27 U.S structural heart occlusion devices market, 2018-2030 (USD Million)
Figure 28 Canada structural heart occlusion devices market, 2018-2030 (USD Million)
Figure 29 Mexico structural heart occlusion devices market, 2018-2030 (USD Million)
Figure 30 Europe structural heart occlusion devices market, 2018-2030 (USD Million)
Figure 31 Germany structural heart occlusion devices market, 2018-2030 (USD Million)
Figure 32 UK structural heart occlusion devices market, 2018-2030 (USD Million)
Figure 33 France structural heart occlusion devices market, 2018-2030 (USD Million)
Figure 34 Italy structural heart occlusion devices market, 2018-2030 (USD Million)
Figure 35 Spain structural heart occlusion devices market, 2018-2030 (USD Million)
Figure 36 Sweden structural heart occlusion devices market, 2018-2030 (USD Million)
Figure 37 Denmark structural heart occlusion devices market, 2018-2030 (USD Million)
Figure 38 Norway structural heart occlusion devices market, 2018-2030 (USD Million)
Figure 39 Asia Pacific structural heart occlusion devices market, 2018-2030 (USD Million)
Figure 40 Japan structural heart occlusion devices market, 2018-2030 (USD Million)
Figure 41 China structural heart occlusion devices market, 2018-2030 (USD Million)
Figure 42 India structural heart occlusion devices market, 2018-2030 (USD Million)
Figure 43 Australia structural heart occlusion devices market, 2018-2030 (USD Million)
Figure 44 Thailand structural heart occlusion devices market, 2018-2030 (USD Million)
Figure 45 South Korea structural heart occlusion devices market, 2018-2030 (USD Million)
Figure 46 Latin America structural heart occlusion devices market, 2018-2030 (USD Million)
Figure 47 Brazil structural heart occlusion devices market, 2018-2030 (USD Million)
Figure 48 Argentina structural heart occlusion devices market, 2018-2030 (USD Million)
Figure 49 MEA structural heart occlusion devices market, 2018-2030 (USD Million)
Figure 50 South Africa structural heart occlusion devices market, 2018-2030 (USD Million)
Figure 51 Saudi Arabia structural heart occlusion devices market, 2018-2030 (USD Million)
Figure 52 UAE structural heart occlusion devices market, 2018-2030 (USD Million)
Figure 53 Kuwait structural heart occlusion devices market, 2018-2030 (USD Million)
Figure 54 Market Participant Categorization
Figure 55 Strategy mapping

Companies Mentioned

The major companies featured in this Structural Heart Occlusion Devices market report include:
  • Abbott
  • Boston Scientific Corporation
  • Occlutech
  • Lifetech Scientific
  • Medtronic
  • W. L. Gore & Associates
  • Lepu Medical Technology (Beijing)Co., Ltd
  • Emtree Medical (Cardia Inc.)
  • Biosense Webster (Johnson & Johnson)
  • PFM Medical GMBH

Table Information

Report AttributeDetails
No. of Pages140
PublishedMay 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 4 Billion
Forecasted Market Value ( USD ) by 2030 $ 6 Billion
Compound Annual Growth Rate7.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Structural Heart Occlusion Devices Market by Product Type, Access Method, End User, Distribution Channel, Material Type - Global Forecast to 2030 - Product Image

Structural Heart Occlusion Devices Market by Product Type, Access Method, End User, Distribution Channel, Material Type - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From
Structural Heart Occlusion Device Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Structural Heart Occlusion Device Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 90 Pages
  • Global
From
Transcatheter Devices Market by Product Type, Application, Access Route, End User, Distribution Channel - Global Forecast to 2030 - Product Image

Transcatheter Devices Market by Product Type, Application, Access Route, End User, Distribution Channel - Global Forecast to 2030

  • Report
  • 188 Pages
  • Global
From
Pediatric Interventional Cardiology Market by Product Type, Application, End User, Age Group - Global Forecast to 2030 - Product Image

Pediatric Interventional Cardiology Market by Product Type, Application, End User, Age Group - Global Forecast to 2030

  • Report
  • 192 Pages
  • Global
From
EU5 Interventional Cardiology Market Outlook to 2033 - Coronary Stents, PTCA Balloon Catheters, Transcatheter Accessories and Others - Product Image

EU5 Interventional Cardiology Market Outlook to 2033 - Coronary Stents, PTCA Balloon Catheters, Transcatheter Accessories and Others

  • Report
  • 167 Pages
  • Europe
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.